Advertisement
Screener

DarioHealth Corp. (DRIO) Graph

DRIO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue (m); Revenue including tax $5.18M; Cost of revenue $1.99M; Research and development $2.10M.
  • 2026-03-31: Revenue (m); Revenue including tax $5.58M; Cost of revenue $2.38M; Research and development $2.38M.
  • 2025-12-31: Revenue (m); Revenue including tax $5.23M*; Cost of revenue $2.43M*; Research and development $2.63M*.
  • 2025-09-30: Revenue (m); Revenue including tax $5.01M; Cost of revenue $1.99M; Research and development $3.33M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

DRIO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Service$2.58MHardware AndConsumable Products$2.59MRevenue$5.18MCost of revenue$1.98MGross profit$3.19MOperating expenses$9.67MOperating income-$6.48MOther income, net$6.00KResearch & development$2.10MPre-tax income-$7.60MIncome tax$328.00KNet income-$7.92M

Contract With Customer Sales Channel

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

DRIO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Consumers$2.67MSales Channel Business ToBusiness To Consumer B2b2c$2.50MRevenue$5.18MCost of revenue$1.98MGross profit$3.19MOperating expenses$9.67MOperating income-$6.48MOther income, net$6.00KResearch & development$2.10MPre-tax income-$7.60MIncome tax$328.00KNet income-$7.92M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30(m)$5.18M$1.99M$2.10M$9.67M$328.00K-$7.92M
2026-03-31(m)$5.58M$2.38M$2.38M$10.51M$57.00K-$8.25M
2025-12-31(m)$5.23M*$2.43M*$2.63M*$11.37M*$83.00K*-$9.03M*
2025-09-30(m)$5.01M$1.99M$3.33M$12.50M$0.00-$10.47M
2025-06-30(m)$5.37M$2.40M$3.72M$12.16M$0.00-$12.99M
2025-03-31(m)$6.75M$2.87M$4.11M$13.29M$22.00K-$9.23M
2024-09-30(m)$7.42M$3.55M$5.45M$15.91M-$13.00K-$12.33M
2024-06-30(m)$6.25M$3.50M$6.81M$18.95M(m)-$13.61M
2024-03-31(m)$5.76M$3.33M$6.64M$20.29M$0.00-$7.17M
2023-09-30(m)$3.52M$2.91M$5.67M$16.16M(m)-$15.73M
2023-06-30(m)$6.15M$4.08M$5.22M$16.09M(m)-$16.59M
2023-03-31(m)$7.07M$3.90M$5.17M$15.58M(m)-$12.82M
2022-09-30(m)$6.61M$4.80M$4.80M$16.37M(m)-$15.63M
2022-06-30(m)$6.18M$5.04M$4.14M$18.49M$1.00K-$18.03M
2022-03-31(m)$8.06M$4.07M$5.93M$19.86M(m)-$15.92M
2021-09-30(m)$5.63M$4.80M$5.51M$23.32M(m)-$22.44M
2021-06-30(m)$5.26M$3.03M$3.74M$19.51M(m)-$17.77M
2021-03-31(m)$3.60M$1.99M$2.65M$15.41M(m)-$14.97M
2020-09-30(m)$2.04M$1.49M$954.00K$7.15M(m)-$6.55M
2020-06-30(m)$1.79M$1.15M$825.00K$4.76M(m)-$4.01M
2020-03-31(m)$1.67M$888.00K$1.23M$10.89M(m)-$9.89M
2019-09-30(m)$1.87M$995.00K$859.00K$3.67M(m)-$2.81M
2019-06-30$1.65M$1.65M$1.32M$991.00K$5.69M(m)-$5.38M
2019-03-31$2.24M$2.24M$1.68M$1.00M$5.92M(m)-$5.38M
2018-12-31$1.70M*(m)(m)(m)(m)(m)(m)
2018-09-30$1.88M$1.88M$1.41M$997.00K$4.52M(m)-$4.06M
2018-06-30$2.06M(m)$1.54M$1.01M$6.32M(m)-$5.84M
2018-03-31$1.76M(m)$1.20M$742.00K$3.47M(m)-$2.92M
2017-09-30$1.38M(m)$1.10M$797.00K$3.25M(m)-$2.97M
2017-06-30$1.21M(m)$850.00K$1.18M$4.48M(m)-$4.09M
2017-03-31$1.01M(m)(m)$469.00K$4.31M(m)-$5.41M
2016-09-30$728.00K(m)$652.00K$659.00K$2.80M(m)-$611.00K
2016-06-30$669.00K(m)$826.00K$521.00K$2.47M(m)-$4.06M
2016-03-31$568.00K(m)$670.00K$397.00K$1.82M(m)-$2.37M
2015-09-30$273.00K(m)$404.00K$667.00K$2.42M(m)-$1.83M
2015-06-30$175.00K(m)$410.00K$441.00K$1.28M(m)-$2.00M
2015-03-31$67.00K(m)$297.00K$883.00K$1.55M(m)-$1.64M
2014-09-30$0.00(m)$585.00K$769.00K$1.92M(m)-$3.08M
2014-06-30$0.00(m)$605.00K$1.33M$3.00M(m)-$3.25M
2014-03-31$0.00(m)$421.00K$1.11M$2.25M(m)-$2.98M
2013-09-30$0.00(m)$0.00$1.08M$3.24M(m)-$3.47M
2013-06-30$0.00(m)$0.00$1.42M$3.60M(m)-$5.29M
2013-03-31(m)(m)(m)$675.00K(m)(m)-$5.23M
2012-09-30(m)(m)(m)$391.27K(m)(m)-$3.06M
2012-06-30(m)(m)(m)$449.15K(m)(m)-$867.23K
2012-03-31(m)(m)(m)$171.67K(m)(m)-$570.88K

Revenue and expense 5 month

Period endNet income
2011-12-31-$385.00K

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30(m)$10.76M$4.37M$4.49M$20.18M$384.00K-$16.17M
2025-06-30(m)$12.12M$5.28M$7.83M$25.45M$22.00K-$22.22M
2024-06-30(m)$12.01M$6.83M$13.45M$39.23M-$1.99M-$20.79M
2023-06-30(m)$13.22M$7.98M$10.39M$31.67M(m)-$29.41M
2022-06-30(m)$14.24M$9.12M$10.06M$38.35M$1.00K-$33.94M
2021-06-30(m)$8.86M$5.17M$6.40M$34.92M(m)-$32.73M
2020-06-30(m)$3.45M$2.04M$2.06M$15.65M(m)-$13.90M
2019-06-30$3.89M$3.89M$3.01M$1.99M$11.61M(m)-$10.76M
2018-06-30$3.81M(m)$2.74M$1.75M$9.78M(m)-$8.76M
2017-06-30$2.22M(m)$1.75M$1.65M$8.79M(m)-$9.51M
2016-06-30$1.24M(m)$1.50M$918.00K$4.29M(m)-$6.42M
2015-06-30$242.00K(m)$707.00K$1.32M$2.82M(m)-$3.64M
2014-06-30$0.00(m)$1.03M$2.44M$5.25M(m)-$6.24M
2013-06-30$0.00(m)$0.00$2.09M$6.67M(m)-$10.51M
2012-06-30(m)(m)(m)$620.82K(m)(m)-$1.44M

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30(m)$17.13M$7.27M$11.16M$37.95M$22.00K-$32.68M
2024-09-30(m)$19.44M$10.37M$18.90M$55.14M-$2.01M-$33.12M
2023-09-30(m)$16.74M$10.88M$16.05M$47.83M(m)-$45.14M
2022-09-30(m)$20.85M$13.92M$14.87M$54.72M$1.00K-$49.58M
2021-09-30(m)$14.48M$11.07M$11.90M$58.24M(m)-$55.17M
2020-09-30(m)$5.50M$3.53M$3.01M$22.80M(m)-$20.45M
2019-09-30(m)$5.76M$4.00M$2.85M$15.28M(m)-$13.56M
2018-09-30$5.69M$5.69M$4.15M$2.75M$14.30M(m)-$12.82M
2017-09-30$3.59M(m)$2.85M$2.45M$12.04M(m)-$12.48M
2016-09-30$1.97M(m)$2.15M$1.58M$7.08M(m)-$7.03M
2015-09-30$515.00K(m)$1.11M$1.99M$5.24M(m)-$5.47M
2014-09-30$0.00(m)$1.61M$3.21M$7.17M(m)-$9.31M
2013-09-30$0.00(m)$0.00$3.17M$9.91M(m)-$13.98M
2012-09-30(m)(m)(m)$1.01M(m)(m)-$4.49M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31(m)$22.36M$9.69M$13.79M$49.32M$105.00K-$41.71M
2024-12-31(m)$27.04M$13.77M$24.18M$71.01M-$1.85M-$42.75M
2023-12-31(m)$20.35M$14.37M$20.25M$62.17M$64.00K-$59.43M
2022-12-31(m)$27.66M$18.00M$19.65M$66.47M$4.00K-$62.19M
2021-12-31(m)$20.51M$16.55M$17.22M$80.46M$32.00K-$76.76M
2020-12-31(m)$7.58M$5.06M$4.43M$32.42M(m)-$29.45M
2019-12-31(m)$7.56M$4.96M$3.69M$20.30M(m)-$17.74M
2018-12-31$7.39M$7.39M$5.63M$3.68M$19.45M(m)-$17.80M
2017-12-31$5.17M(m)$3.86M$3.30M$15.73M(m)-$15.74M
2016-12-31$2.80M(m)(m)$2.15M$10.27M(m)-$10.89M
2015-12-31$823.00K(m)$1.68M$2.56M$6.84M(m)-$7.14M
2014-12-31$51.00K(m)$2.27M$3.94M$8.65M(m)-$12.88M
2013-12-31$0.00(m)$0.00$4.91M$13.56M(m)-$13.93M
2012-12-31(m)(m)(m)$1.50M(m)(m)-$5.69M

Similar stocks

Stock NameCountryMarket CapPE Ratio
CVRx, Inc. (CVRX)United States$0.067B-2.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
TELA Bio, Inc. (TELA)United States$0.057B-0.82
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02